Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts. Show more
Location: 300 5th Avenue, Waltham, MA, 02451, United States | Website: https://crescentbiopharma.com | Industry: Biotechnology | Sector: Healthcare
Market Cap
183.8M
52 Wk Range
$10.83 - $63.00
Previous Close
$13.23
Open
$13.21
Volume
64,224
Day Range
$13.01 - $13.80
Enterprise Value
36.8M
Cash
152.6M
Avg Qtr Burn
-6.269M
Insider Ownership
6.62%
Institutional Own.
77.39%
Qtr Updated
06/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
SQ Dalcinonacog alfa (DalcA) Details Hemophilia, Genetic disorder | Failed Discontinued | |
Marzeptacog alfa (MarzAA) Details Hemophilia, Blood disorder, Rare genetic disease | Failed Discontinued |